Biblio

Author Title Type [ Year(Desc)]
Filters: Author is Yu, Li  [Clear All Filters]
2013
Zhang C-Y, Wang S-H, Huang W-R, Guo G-H, Zhang Z-H, Mou W-J, Yu L, Tian Y-P. A Novel Differential Predict Model Based on Matrix-Assisted Laser Ionization Time-of-Flight Mass Spectrometry and Serum Ferritin for Acute Graft-versus-Host Disease. Biomed Res Int. 2013;2013:563751.
2014
Luo L, Zhang L, Cai B, Li H, Huang W, Jing Y, Zhu H, Zhao Y, Bo J, Wang Q, et al. Post-transplant lymphoproliferative disease after allogeneic hematopoietic stem cell transplantation: A single-center experience. Ann Transplant. 2014;19:6-12.
Chai G, Wang Z, Tang X, Yu L, Qi G, Wang D, Yan X, Kong Y, Zhou G. R2R3-MYB gene pairs in Populus: evolution and contribution to secondary wall formation and flowering time. J Exp Bot. 2014.
Liu M, Li Y, Zhang Y, Zhao X, Zhai B, Zhang Q, Wang L, Zhao Y, Li H, Wang Q, et al. Secondary Antifungal Prophylaxis in Hematological Malignancy Patients with Previous Invasive Fungal Disease: A Retrospective Analysis. PLoS One. 2014;9(12):e115461.
Jing Y, Chen H, Liu M, Zhou M, Guo Y, Gao C, Wang Q, Li H, Zhao Y, Bo J, et al. Susceptibility Of Ph-Positive All To Tki Therapy Associated With Bcr-Abl Rearrangement Patterns: A Retrospective Analysis. PLoS One. 2014;9(11):e110431.
2015
Li D, Wang L, Zhu H, Dou L, Liu D, Fu L, Ma C, Ma X, Yao Y, Zhou L, et al. Efficacy of Allogeneic Hematopoietic Stem Cell Transplantation in Intermediate-Risk Acute Myeloid Leukemia Adult Patients in First Complete Remission: A Meta-Analysis of Prospective Studies. PLoS One. 2015;10(7):e0132620.
Sun Y, Meng F, Han M, Zhang X, Yu L, Huang H, Wu D, Ren H, Wang C, Shen Z, et al. Epidemiology, management and outcome of invasive fungal disease in patients undergoing haematopoietic stem cell transplantation in China: a multicentre prospective observational study. Biol Blood Marrow Transplant. 2015.
2019
Xu Q, Li Y, Jing Y, Lv N, Wang L, Li Y, Yu L. Epigenetic modifier gene mutations-positive AML patients with intermediate-risk karyotypes benefit from decitabine with CAG regimen. Int J Cancer. 2019.
2020
Luo X, Zhou J, Wang Z, He Y, Yu L, Ma S, Wang S, Wang X, Yuan Y, Li D, et al. An inhibitor role of Nrf2 in the regulation of myocardial senescence and dysfunction after myocardial infarction. Life Sci. 2020:118199.
Xiaojie S, Yu L, Lei Y, Guang Y, Min Q. Neutralizing antibodies targeting SARS-CoV-2 spike protein. Stem Cell Res. 2020;50:102125.
2021
Wang H, Li Y, Zhou W, Wang R, Li Y, Yu L. Pre-transplant therapy for patients with myelodysplastic syndromes: A systematic review and meta-analysis. Leuk Res. 2021;110:106645.
Sun J-M, Yu L. Reply: Salvia miltiorrhiza Injection Promotes the Adipogenic Differentiation of Human Adipose-Derived Stem Cells. Plast Reconstr Surg. 2021.
2022
Gong M, Yan F, Yu L, Li F. A dopamine-methacrylated hyaluronic acid hydrogel as an effective carrier for stem cells in skin regeneration therapy. Cell Death Dis. 2022;13(8):738.
2023
Van Timothee BMvuama, Du J, Ren Y, He Y, Ruan Y, Liu X, Chen L, Wen J, Ding R, Yu L, et al. The effect of iron overload on the mobilization of peripheral blood hematopoietic stem cells in pediatric patients with thalassemia major. Acta Haematol. 2023.
Chen X, Yu L, Zhou J, Ren J, Wang S, Tan Y, Ding Y. Inhibition of p62 and/or NFE2L2 induced autophagy impaires esophageal squamous cell cancer metastasis by reversing EMT. Gene. 2023:147194.
2024
Ren X, Yang L, Muhammad Y, Xie Y, Lin X, Yu L, Cao Y, Ding M, Jiang Y, Rong J. The GaKAN2, a KANADI transcription factor, modulates stem trichomes in Gossypium arboreum. Mol Genet Genomics. 2024;299(1):19.
Zeng M, Zhang W, Li Y, Yu L. Harnessing adenovirus in cancer immunotherapy: evoking cellular immunity and targeting delivery in cell-specific manner. Biomark Res. 2024;12(1):36.
Xu Z-L, Xu L-P, Zhang Y-C, Zhou Y-H, Jiang E-L, Zhang J-P, Fu B, Ouyang G-F, Song X-M, Zhang X-J, et al. The outcome and predictive model of allogeneic hematopoietic stem cell transplantation among elderly patients with severe aplastic anemia from the Chinese Blood and Marrow Transplant Registry Group. Haematologica. 2024.